The IMI is a collaboration between the European Union and the European pharmaceutical industry. As the world’s biggest life sciences public-private partnership, the IMI facilitates collaboration and provides funding for healthcare stakeholders to conduct pan-European projects to improve healthcare around various key themes. Consortia of healthcare stakeholders come together to apply for highly-competitive grants dedicated to these themes. In December 2016, ICHOM – together